PrognosisThe future of health, and the business of getting there
The Future of Medicine
Data & Disruption
Data, documents and interviews show how a focus on cutting prices has come with risks to consumer health.
The Business of Drugs
Patients, Profits & Policy
Key Takeaways From China's National People’s Congress
Fraser Howie, co-author of "Red Capitalism" and "Privatizing China," talks about China's National People's Congress and the government's policies. The government wraps up its annual policy conference this week with the passage of a new foreign investment law that it hopes will keep global companies enthusiastic about the world’s second largest economy, Howie speaks on "Bloomberg Markets: Asia." (Source: Bloomberg)
Johnson & Johnson Must Pay Dying Woman
2019 Will Be a Better Year Than Last Year, Says Ping An’s Lee
Elanco Animal Health Has a 'Very Clear' Strategy, CEO Says
Bristol-Myers CEO Says Celgene Deal Not Defensive
In Case You Missed It
Bloomberg's index looks at whether Trump's rhetoric on prices has had a major impact.
A version of the club drug is expected to be approved for depression in March. Researchers think it could help treat suicidal thinking.
Fentanyl is so potent that a few milligrams can be fatal. Could it be used to attack the U.S.?
Bloomberg’s analysis offers the first real glimpse into the money at play in what may be one of the biggest legal challenges in U.S. history.